Abstract
Particles from polylactide (PLA), polylactide/glycolide (PLA/GA) and solid lipid nanoparticles (SLN) were produced and loaded with different amounts of magnetite. The in vitro cytotoxicity was determined to assess their toxicological acceptance as intravenous formulation for magnetic resonance imaging and as potential carrier for drug targeting. Viability determinations were performed in suspensions of human granulocytes using the dimethylthiazolyldiphenyltetrazolium (MTT) test. Particle internalization by the granulocytes was followed using luminol enhanced chemiluminescence (CL). The effective concentrations to reduce the viability to 50% (ED 50%) were 0.38% and 0.30% for high and low molecular weight PLA, 0.15% for PLA/GA. The mechanism of toxicity is the intracellular uptake, with the highest toxicity being observed for the faster degrading polymers, low molecular weight PLA and PLA/GA. The solid lipid nanoparticles proved to be the least cytotoxic preparation with an effective concentration (ED 50%) above 10%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
